Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer immunotherapy strategies that target the cGAS-STING pathway
Zhuoying Tian, Yue Zeng, Yurong Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically ‘cold’ tumor models
Barry E. Kennedy, Erin B. Noftall, Cheryl A. Dean, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Understanding nucleic acid sensing and its therapeutic applications
Ling-Zu Kong, Seok‐min Kim, Chunli Wang, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2320-2331
Open Access | Times Cited: 29
The tumor microenvironment: shaping cancer progression and treatment response
Sharav Desai, Vipul P. Patel, Kunal Bhosle, et al.
Journal of Chemotherapy (2024), pp. 1-30
Closed Access | Times Cited: 13
Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma
Dongquan Xiang, Xin-Li Han, Jianxiong Li, et al.
Materials Today Bio (2023) Vol. 20, pp. 100675-100675
Open Access | Times Cited: 21
Interferons and interferon-related pathways in heart disease
Duc Tin Tran, Sri Nagarjun Batchu, Andrew Advani
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 8
Mesenchymal Stromal Cells Increase the Natural Killer Resistance of Circulating Tumor Cells via Intercellular Signaling of cGAS‐STING‐IFNβ‐HLA
Yi Ye, Guihui Qin, Hongmei Yang, et al.
Advanced Science (2024) Vol. 11, Iss. 21
Open Access | Times Cited: 7
Role of STING in the treatment of non-small cell lung cancer
Wenhua Tang, Wenjie Zhou, Mei Ji, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Treg-derived TGF-β1 dampens cGAS-STING signaling to downregulate the expression of class I MHC complex in multiple myeloma
Disi Zhang, Dong Zhan, Rui Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Inactivated cGAS‐STING Signaling Facilitates Endocrine Resistance by Forming a Positive Feedback Loop with AKT Kinase in ER+HER2– Breast Cancer
Kai‐Ming Zhang, De‐Chang Zhao, Zeyu Li, et al.
Advanced Science (2024)
Open Access | Times Cited: 5
Combination of a STING Agonist and Photothermal Therapy Using Chitosan Hydrogels for Cancer Immunotherapy
Cunguo Chen, Murong Hu, Yunyun Cao, et al.
Biomacromolecules (2023) Vol. 24, Iss. 6, pp. 2790-2803
Closed Access | Times Cited: 11
A central role of stimulator of interferon genes’ adaptor protein in defensive immune response
Anju Kaushal
Immunologic Research (2025) Vol. 73, Iss. 1
Closed Access
STING and metabolism-related diseases: Roles, mechanisms, and applications
Zhengyang Zhang, Xirui Wang, Chuangchuang Zhao, et al.
Cellular Signalling (2025) Vol. 132, pp. 111833-111833
Closed Access
Dual and multi-immune activation strategies for emerging cancer immunotherapy
Ying Zhang, Liang Liu, Huilan He, et al.
Materials Today (2024)
Closed Access | Times Cited: 3
Differential Response to Local Stimulator of Interferon Genes Agonist Administration in Tumors with Various Stimulator of Interferon Genes Statuses
Alina Drzyzga, Justyna Czapla, Sybilla Matuszczak, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 175-175
Open Access
Core–Satellite Nanoassembly Overcomes Spatial Heterogeneity of Dendric Cell Distribution in Pancreatic Tumors for Effective Chemoimmunotherapy
Gengjia Chen, Bo Li, Tan Li, et al.
ACS Nano (2025)
Closed Access
PD-L1 importance in malignancies comprehensive insights into the role of PD-L1 in malignancies: from molecular mechanisms to therapeutic opportunities
Mojdeh Soltani, Mohammad Abbaszadeh, Hamed Fouladseresht, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Cancer stem cell, chromosomal instability, and cancer immunity
Laxmi Kumari, Saloni Munjal, Reena Yadav, et al.
Exploration of Immunology (2024), pp. 169-188
Open Access | Times Cited: 1
STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity
Mohammad Mahdi Mokhtari Tabar, Mahnaz Fathi, Fatemeh Kazemi, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Targeting STING signaling for the optimal cancer immunotherapy
Yan Xu, Ying Xiong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Impaired Integrated Stress Response and Mitochondrial Integrity Modulate Genotoxic Stress Impact and Lower the Threshold for Immune Signalling
Mihaela Temelie, Rubab Talpur, Marta Domínguez-Prieto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5891-5891
Open Access | Times Cited: 3
Carbonic Anhydrase 4 Serves as A Novel Prognostic Biomarker and Therapeutic Target for Non-Small Cell Lung Cancer: A Study Based on TCGA Samples
Bo Xu, Yang Lou, Xiaoyi Xu, et al.
Combinatorial Chemistry & High Throughput Screening (2023) Vol. 26, Iss. 14, pp. 2527-2540
Closed Access | Times Cited: 3
STING-driven activation of T cells: relevance for the adoptive cell therapy of cancer
Fabian Richter, Christophe Paget, Lionel Apétoh
Cell Stress (2023) Vol. 7, Iss. 11, pp. 95-104
Open Access | Times Cited: 3
A novel self-assembled nucleobase-nanofiber platform of CDN to activate the STING pathway for synergistic cancer immunotherapy
Wenpei Dong, Lingyun Xu, Chun Ju Chang, et al.
Colloids and Surfaces B Biointerfaces (2023) Vol. 232, pp. 113597-113597
Closed Access | Times Cited: 2
Cytosolic delivery of anionic cyclic dinucleotide STING agonists with locally supercharged viral capsids
Paul Huang, Paige E. Pistono, Hannah S. Martin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Therapeutic targeting of cGAS–STING pathway in lung cancer
Jinli Wang, Lumin Xing
Cell Biology International (2024) Vol. 49, Iss. 2, pp. 129-138
Closed Access
Page 1 - Next Page

Scroll to top